{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:00:41Z","timestamp":1793448041836,"version":"4.5.0"},"reference-count":216,"publisher":"Baishideng Publishing Group Inc.","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i39.8720","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T08:42:46Z","timestamp":1476952966000},"page":"8720","source":"Crossref","is-referenced-by-count":142,"title":["Update on occult hepatitis B virus infection"],"prefix":"10.3748","volume":"22","author":[{"given":"Manoochehr","family":"Makvandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"World Health Organization. Hepatitis B Fact Sheet N204: Hepatitis B. World Health Organization, 2013. Accessed January 23, 2013. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/<\/ext-link>."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1979.19680104098.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200012)62:4&lt;450::AID-JMV9&gt;3.0.CO;2-Y"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00344.x"},{"key":"ref5","unstructured":"Giudice CL, Martinengo M, Pietrasanta P, Bocciardo L, Malavasi C, Rastelli S, Faraci M, Tripodi G. Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation. Blood Transfus 2008;6:46-50."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2010.02.003"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054486"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.10.007"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i6.1794"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i13.3531"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10:1-98.","DOI":"10.1007\/s12072-015-9675-4"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.07.014"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002;2:479-486.","DOI":"10.1016\/S1473-3099(02)00345-6"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/v6041590"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.209148"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.037"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Escobedo-Melendez G, Panduro A, Fierro NA, Roman S. High prevalence of occult hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico. Mem Inst Oswaldo Cruz 2014;109:728-737.","DOI":"10.1590\/0074-0276140058"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.2008\/002824-0"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21862"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160613595"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009;50:264-272.","DOI":"10.1016\/j.jhep.2008.09.017"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2010.01036.x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.5805"},{"key":"ref24","unstructured":"Elgohry I, Elbanna A, Hashad D. Occult hepatitis B virus infection in a cohort of Egyptian chronic hemodialysis patients. Clin Lab 2012;58:1057-1061."},{"key":"ref25","unstructured":"Alizadeh Z, Milani S, Sharifi Z. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study. Arch Iran Med 2014;17:106-107."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.16873"},{"key":"ref27","unstructured":"Sharifi-Mood B, Sanei-Moghaddam E, Khosravi S. Occult hepatitis B Virus infection among anti-HBc only positive individuals in the southeast of Iran in high prevalence of HBV infection region. IRCMJ 2009;11:90-92."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.6590"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.","DOI":"10.1016\/0140-6736(90)91874-A"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92599-6"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10206"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.16.8882-8892.2003"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.08.003"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1086\/529437"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20748"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10205"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1994.1127"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1159\/000121363"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142515"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24257"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 1999;45:284-288.","DOI":"10.1136\/gut.45.2.284"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12260"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Branco F, Mattos AA, Coral GP, Vanderborght B, Santos DE, Fran&ccedil;a P, Alexandre C. Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil. Arq Gastroenterol 2007;44:58-63.","DOI":"10.1590\/S0004-28032007000100013"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.24.15578-15581.2005"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.5.2858"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1381"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Chen SY, Kao CF, Chen CM, Shih CM, Hsu MJ, Chao CH, Wang SH, You LR, Lee YH. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003;278:591-607.","DOI":"10.1074\/jbc.M204241200"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00296-9"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1701"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.05.052"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, Kushiyama Y, Uchida Y, Ihihara S, Akagi S. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999;58:201-207.","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.11.4068-4071.2002"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Besisik F, Karaca C, Aky&uuml;z F, Horosanli S, Onel D, Badur S, Sever MS, Danalioglu A, Demir K, Kaymakoglu S. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol 2003;38:506-510.","DOI":"10.1016\/S0168-8278(02)00457-9"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2004"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Khattab E, Chemin I, Vuillermoz I, Vieux C, Mrani S, Guillaud O, Trepo C, Zoulim F. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy. J Clin Virol 2005;33:150-157.","DOI":"10.1016\/j.jcv.2004.10.016"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i21.3420"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR. Intervirology 2007;50:241-244.","DOI":"10.1159\/000101911"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21284"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21488"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06006.x"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3350\/kjhep.2011.17.3.206"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2011.00645.x"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.10134"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Kishk R, Atta HA, Ragheb M, Kamel M, Metwally L, Nemr N. Genotype characterization of occult hepatitis B virus strains among Egyptian chronic hepatitis C patients. East Mediterr Health J 2014;20:130-138.","DOI":"10.26719\/2014.20.2.130"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0037-2015"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02394.x"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006;35:14-20.","DOI":"10.1016\/j.jcv.2005.04.003"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05950.x"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-011-9381-x"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21529"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0327-7"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24384"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i37.13530"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12093"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.04.021"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31828e9b99"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit166"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045750"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Panigrahi R, Majumder S, Gooptu M, Biswas A, Datta S, Chandra PK, Banerjee A, Chakrabarti S, Bandopadhyay D, De BK. Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. Ann Hepatol 2012;11:870-875.","DOI":"10.1016\/S1665-2681(19)31412-7"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-011-0093-9"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-53"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.4021\/jocmr2009.12.1282"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-008-8194-9"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1159\/000160217"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1086\/520989"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.05.020"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.2450\/2008.0062-08"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.03056.x"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.95043"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2007.07.001"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Kishk R, Nemr N, Elkady A, Mandour M, Aboelmagd M, Ramsis N, Hassan M, Soliman N, Iijima S, Murakami S. Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt. Virol J 2015;12:153.","DOI":"10.1186\/s12985-015-0389-y"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2010;14:e308-e310.","DOI":"10.1016\/j.ijid.2009.05.011"},{"key":"ref96","unstructured":"Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Anti-HBc &amp; amp; HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 2006;123:37-42."},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.182216"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.01975.x"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-007-9017-2"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0010-z"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.548"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu617"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1080\/08860220600925602"},{"key":"ref105","unstructured":"Fabrizi F, Lunghi G, Martin P. Hepatitis B virus infection in hemodialysis: recent discoveries. J Nephrol 2002;15:463-468."},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34613"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.22674"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987"},{"key":"ref109","unstructured":"Neisi N, Makvandi M, Samarbaf-Zadeh AR. A study on genotypes of hepatitis B virus among hemodialysis patients in Khuzestan province. Jundishapur J Microbiol 2011;4:65-70."},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.23686"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"Cabrerizo M, Bartolom&eacute; J, De Sequera P, Caramelo C, Carre\u00f1o V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol 1997;8:1443-1447.","DOI":"10.1681\/ASN.V891443"},{"key":"ref112","unstructured":"Siagris D, Christofidou M, Triga K, Pagoni N, Theocharis GJ, Goumenos D, Lekkou A, Thomopoulos K, Tsamandas AC, Vlachojannis J. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection. J Nephrol 2006;19:327-333."},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.11648"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.136553"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12807"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.28708"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1159\/000219385"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20143782"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.02.013"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i31.5048"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000294"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.14571"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.09.007"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-016-0433-4"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21612"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-9-200111060-00006"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080310"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-5-613"},{"key":"ref130","doi-asserted-by":"crossref","unstructured":"Anvari FA, Alavian SM, Norouzi M, Mahabadi M, Jazayeri SM. Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran. Oman Med J 2014;29:92-96.","DOI":"10.5001\/omj.2014.23"},{"key":"ref131","unstructured":"Agarwal N, Naik S, Aggarwal R, Singh H, Somani SK, Kini D, Pandey R, Choudhuri G, Saraswat VA, Naik SR. Occult hepatitis B virus infection as a cause of cirrhosis of liver in a region with intermediate endemicity. Indian J Gastroenterol 2003;22:127-131."},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.05.043"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21239"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-324"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1159\/000187720"},{"key":"ref136","doi-asserted-by":"crossref","unstructured":"Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, Trabaud MA, Chevallier P, Chevallier M, Zoulim F. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 2007;79:1075-1081.","DOI":"10.1002\/jmv.20943"},{"key":"ref137","doi-asserted-by":"crossref","unstructured":"Hui CK, Lau E, Wu H, Monto A, Kim M, Luk JM, Lau GK, Wright TL. Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection. J Clin Virol 2006;35:185-192.","DOI":"10.1016\/j.jcv.2005.07.003"},{"key":"ref138","doi-asserted-by":"crossref","unstructured":"Silva Cd, Gon&ccedil;ales NS, Pereira JS, Escanhoela CA, Pavan MH, Gon&ccedil;ales FL. The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients. Braz J Infect Dis 2004;8:431-439.","DOI":"10.1590\/S1413-86702004000600007"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05706.x"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.011"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2009.06.005"},{"key":"ref142","doi-asserted-by":"crossref","unstructured":"Uchida T, Saitoh T, Shinzawa H. Mutations of the X region of hepatitis B virus and their clinical implications. Pathol Int 1997;47:183-193.","DOI":"10.1111\/j.1440-1827.1997.tb04479.x"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i44.4853"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.05.014]"},{"key":"ref145","doi-asserted-by":"crossref","unstructured":"Raimondo G, Burk RD, Lieberman HM, Muschel J, Hadziyannis SJ, Will H, Kew MC, Dusheiko GM, Shafritz DA. Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology 1988;166:103-112.","DOI":"10.1016\/0042-6822(88)90151-1"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02481.x"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198110293051807"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840170106"},{"key":"ref149","unstructured":"Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21:313-321."},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990209)80"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80134-8"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004332"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.09.005"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290520"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21702"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-2007"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12482"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24416"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13099"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12219"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgr108"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19650-0"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2012.05.008"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24551"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204835"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328313139d"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.09.010"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12567"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.11.009"},{"key":"ref170","doi-asserted-by":"crossref","unstructured":"Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, Zetterman RK, Pruett TL, Ishitani MB, Hoofnagle JH. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997;113:1668-1674.","DOI":"10.1053\/gast.1997.v113.pm9352871"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1590\/0074-0276108052013019"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.10.042"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00018-11"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-012-0182-9"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1086\/597614"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i38.4258"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00165-X"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.07.016"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0b013e3283498e87"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70167-4"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21642"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnci.2015.01.004"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.25726"},{"key":"ref184","unstructured":"Cheung WI, Lin SY, Leung VK, Fung KS, Lam YK, Lo FH, Chau TN. Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy. Hong Kong Med J 2011;17:376-380."},{"key":"ref185","unstructured":"Slusarczyk J, Ma\u0142kowski P, Bobilewicz D, Juszczyk G. Cross-sectional, anonymous screening for asymptomatic HCV infection, immunity to HBV, and occult HBV infection among health care workers in Warsaw, Poland. Przegl Epidemiol 2012;66:445-451."},{"key":"ref186","unstructured":"US Public Health Service. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep 2001;50:1-52."},{"key":"ref187","unstructured":"Squadrito G, Spinella R, Raimondo G. The clinical significance of occult HBV infection. Ann Gastroenterol 2014;27:15-19."},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.11599\/germs.2015.1081"},{"key":"ref189","unstructured":"Chiarakul S, Eunumjitkul K, Vorapimol AR, Kaewkungwal J, Chimparlee N, Poovorawan Y. Response of health care workers with isolated antibody to hepatitis B core antigen to hepatitis B vaccine. Southeast Asian J Trop Med Public Health 2011;42:831-838."},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.044"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05483"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.0182"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22199"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0806-7"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.06.027"},{"key":"ref197","doi-asserted-by":"crossref","unstructured":"Talotta R, Atzeni F, Sarzi Puttini P. Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report. BMC Pharmacol Toxicol 2016;17:17.","DOI":"10.1186\/s40360-016-0060-2"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.10.017"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000232232.41877.2a"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012359400193"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0359-5"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-163493"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2324"},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000083343"},{"key":"ref206","doi-asserted-by":"crossref","unstructured":"Kn&ouml;ll A, Boehm S, Hahn J, Holler E, Jilg W. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2004;33:925-929.","DOI":"10.1038\/sj.bmt.1704457"},{"key":"ref207","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.01.018"},{"key":"ref208","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000151661.52601.FB"},{"key":"ref209","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701411441"},{"key":"ref210","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-009-9019-1"},{"key":"ref211","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.7081"},{"key":"ref212","doi-asserted-by":"crossref","unstructured":"Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, Kao WY, Chiu CF, Lin SF, Lin J. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology 2014;59:2092-2100.","DOI":"10.1002\/hep.26718"},{"key":"ref213","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.947978"},{"key":"ref214","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2012.10.007"},{"key":"ref215","unstructured":"Madali\u0144ski K, Sylvan SP, Hellstrom U, Miko\u0142ajewicz J, Dzierzanowska-Fangrat K. Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B vaccine. Med Sci Monit 2004;10:PI10-PI17."},{"key":"ref216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041573"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i39\/8720.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T20:36:52Z","timestamp":1657485412000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i39\/8720.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":216,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i39.8720","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}